MacroGenics, Inc. (NASDAQ:MGNX) Q2 2024 Earnings Conference Call November 5, 2024 4:30 PM ET
Company Participants
James Karrels – Senior Vice President, Chief Financial Officer and Secretary
Scott Koenig – President and Chief Executive Officer
Conference Call Participants
Nicholas Lorusso – TD Cowen
Jonathan Chang – Leerink Partners
Reena Patel – Citi
Etzer Darout – BMO Capital Markets
Jonathan Miller – Evercore ISI
Silvan Tuerkcan – Citizens JMP Securities
Mayank Mamtani – B. Riley Securities
Peter Lawson – Barclays
Stephen Willey – Stifel
Operator
Good afternoon. We will begin the MacroGenics 2024 Third Quarter Corporate Progress and Financial Results Conference Call in just a moment. All participants are in a listen-only mode at the moment and we will conduct a question-and-answer session at the conclusion of the call.
At this point, I will turn the call over to Jim Karrels, Senior Vice President, Chief Financial Officer of MacroGenics.
James Karrels
Thank you, operator. Good afternoon, and welcome to MacroGenics’ conference call to discuss our third quarter 2024 financial and operational results. For anyone who has not had the chance to review these results, we issued a press release this afternoon outlining today’s announcements.
This release is available under the Investors tab on our website at macrogenics.com. You may also listen to this conference call via webcast on our website, where it will be archived for 30 days beginning approximately two hours after the call is completed.
I would like to alert listeners that today’s discussion will include statements about the company’s future expectations, plans and prospects that constitute forward-looking statements for purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk
Credit: Source link
